Gotham Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $487K | Buy |
60,203
+7,534
| +14% | +$61K | ﹤0.01% | 1329 |
|
|
2025
Q1 | $441K | Sell |
52,669
-35,214
| -40% | -$295K | ﹤0.01% | 1271 |
|
|
2024
Q4 | $696K | Buy |
87,883
+40,224
| +84% | +$319K | 0.01% | 1029 |
|
|
2024
Q3 | $397K | Buy |
+47,659
| New | +$397K | ﹤0.01% | 1159 |
|
|
2024
Q2 | – | Sell |
-25,322
| Closed | -$153K | – | 1414 |
|
|
2024
Q1 | $153K | Buy |
+25,322
| New | +$153K | ﹤0.01% | 1310 |
|
|
2021
Q4 | – | Sell |
-10,629
| Closed | -$57K | – | 1135 |
|
|
2021
Q3 | $57K | Sell |
10,629
-10,300
| -49% | -$55.2K | ﹤0.01% | 1002 |
|
|
2021
Q2 | $107K | Buy |
+20,929
| New | +$107K | ﹤0.01% | 972 |
|
|
2020
Q4 | – | Sell |
-11,503
| Closed | -$45K | – | 989 |
|
|
2020
Q3 | $45K | Sell |
11,503
-660
| -5% | -$2.58K | ﹤0.01% | 1002 |
|
|
2020
Q2 | $58K | Sell |
12,163
-1,213
| -9% | -$5.78K | ﹤0.01% | 1025 |
|
|
2020
Q1 | $47K | Sell |
13,376
-1,102
| -8% | -$3.87K | ﹤0.01% | 1029 |
|
|
2019
Q4 | $70K | Buy |
+14,478
| New | +$70K | ﹤0.01% | 1082 |
|
|
2019
Q3 | – | Sell |
-30,883
| Closed | -$221K | – | 1082 |
|
|
2019
Q2 | $221K | Sell |
30,883
-18,631
| -38% | -$133K | ﹤0.01% | 1044 |
|
|
2019
Q1 | $702K | Buy |
+49,514
| New | +$702K | 0.01% | 759 |
|